Highbridge Capital Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-10,474
| Closed | -$567K | – | 892 |
|
|
2017
Q1 | $567K | Sell |
10,474
-2,071
| -17% | -$112K | 0.01% | 680 |
|
|
2016
Q4 | $666K | Sell |
12,545
-1,379
| -10% | -$73.2K | 0.01% | 569 |
|
|
2016
Q3 | $844K | Buy |
+13,924
| New | +$844K | 0.01% | 548 |
|
|
2015
Q4 | – | Sell |
-1,931
| Closed | -$305K | – | 859 |
|
|
2015
Q3 | $305K | Buy |
+1,931
| New | +$305K | ﹤0.01% | 727 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 840 |
|
|
2014
Q4 | – | Sell |
-1,169
| Closed | -$227K | – | 784 |
|
|
2014
Q3 | $227K | Buy |
+1,169
| New | +$227K | ﹤0.01% | 770 |
|
|
2014
Q2 | – | Sell |
-3,633
| Closed | -$963K | – | 748 |
|
|
2014
Q1 | $963K | Buy |
3,633
+2,214
| +156% | +$587K | 0.01% | 427 |
|
|
2013
Q4 | $516K | Buy |
+1,419
| New | +$516K | 0.01% | 482 |
|
|
2013
Q3 | – | Sell |
-862
| Closed | -$202K | – | 930 |
|
|
2013
Q2 | $202K | Buy |
+862
| New | +$202K | ﹤0.01% | 835 |
|